These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15497472)
1. The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen. Herrmann W; Stöckle M; Sand-Hill M; Hübner U; Herrmann M; Obeid R; Wullich B; Loch T; Geisel J Clin Chem Lab Med; 2004; 42(9):1051-7. PubMed ID: 15497472 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of complexed prostate-specific antigen for prostate cancer]. Su HW; Li Y; Xu P Zhonghua Nan Ke Xue; 2003 Sep; 9(6):431-3. PubMed ID: 14574807 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis. Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940 [TBL] [Abstract][Full Text] [Related]
4. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter. Horninger W; Cheli CD; Babaian RJ; Fritsche HA; Lepor H; Taneja SS; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Bartsch G Urology; 2002 Oct; 60(4 Suppl 1):31-5. PubMed ID: 12384160 [TBL] [Abstract][Full Text] [Related]
5. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572 [TBL] [Abstract][Full Text] [Related]
6. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. Partin AW; Brawer MK; Bartsch G; Horninger W; Taneja SS; Lepor H; Babaian R; Childs SJ; Stamey T; Fritsche HA; Sokoll L; Chan DW; Thiel RP; Cheli CD J Urol; 2003 Nov; 170(5):1787-91. PubMed ID: 14532777 [TBL] [Abstract][Full Text] [Related]
7. Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial. Okihara K; Ukimura O; Nakamura T; Ushijima S; Mizutani Y; Kawauchi A; Naya Y; Kojima M; Miki T Urology; 2006 Feb; 67(2):328-32. PubMed ID: 16461082 [TBL] [Abstract][Full Text] [Related]
8. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer. Tello FL; Prats CH; González MD Clin Chem Lab Med; 2001 Feb; 39(2):116-20. PubMed ID: 11341744 [TBL] [Abstract][Full Text] [Related]
9. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428 [TBL] [Abstract][Full Text] [Related]
10. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL. Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099 [TBL] [Abstract][Full Text] [Related]
11. Effect of hemodialysis on serum complexed prostate-specific antigen levels. Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041 [TBL] [Abstract][Full Text] [Related]
12. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign. Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164 [TBL] [Abstract][Full Text] [Related]
14. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer]. Chen ZH; Zhao J; Wu JM; Xiao CG Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329 [TBL] [Abstract][Full Text] [Related]
15. Complexed PSA in routine diagnosis. Oremek GM; Sapoutzis N; Eden F; Jonas D Anticancer Res; 2003; 23(2A):975-7. PubMed ID: 12820333 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer. Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145 [TBL] [Abstract][Full Text] [Related]
17. Can complexed prostate specific antigen enhance prostate cancer detection in Japanese men? Okihara K; Ukimura O; Nakamura T; Mizutani Y; Kawauchi A; Naya Y; Uchida M; Ogiwara T; Miki T Eur Urol; 2004 Jul; 46(1):57-64. PubMed ID: 15183548 [TBL] [Abstract][Full Text] [Related]
18. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer? Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592 [TBL] [Abstract][Full Text] [Related]
19. Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA. Parsons JK; Brawer MK; Cheli CD; Partin AW; Djavan R BJU Int; 2004 Jul; 94(1):47-50. PubMed ID: 15217429 [TBL] [Abstract][Full Text] [Related]
20. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]